|  | Webinar: Five Common Mistakes in Panel Management Wednesday, July 14, 2021 | 1pm ET / 10am PT It takes time and focus to keep your panel in good health. By learning common pitfalls, this webinar will assist you in refining your panel management strategy and best practices to keep your respondents motivated and engaged. Register now. |
Featured Story | By Nick Paul Taylor A phase 3 clinical trial of AstraZeneca’s extended-release diabetes drug Bydureon in adolescents has met its primary endpoint. The study tested a once-weekly formulation of the glucagon-like peptide-1 receptor agonist exenatide to support a planned filing for approval with the FDA. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor The FDA has accepted Roche’s Port Delivery System with ranibizumab (PDS) for priority review. Roche is seeking approval for the drug delivery implant to free patients with wet age-related macular degeneration from the need to undergo frequent eye injections. read more By Nick Paul Taylor GlaxoSmithKline has put long-acting injectables at the heart of plans to grow its HIV business. GSK is looking to transition to a portfolio built around cabotegravir to mitigate the loss of patent protection on dolutegravir and hold off a challenge from Gilead and Merck. read more By Nick Paul Taylor The European Commission has approved Roche’s Enspryng in neuromyelitis optica spectrum disorder. Roche is looking to subcutaneous administration, which could support dosing at home, to differentiate Enspryng from Alexion’s Soliris in the EU. read more By Noah Higgins-Dunn Viatris, the newly-formed company that combined Mylan and Pfizer's Upjohn unit late last year, said it's "pleased" with the Kansas federal court's decision to dismiss all claims related to the Racketeer Influenced and Corrupt Organizations Act, including charges against the company's former CEO Heather Bresch, in an ongoing class action case. read more Resources Sponsored by: WCG Engage Independent Expert Endpoint Adjudication and Data Monitoring Committees in a strategic manner to identify methods for retrospective and prospective evaluations that may improve competitive advantage and bolster regulatory submissions. Sponsored by: PA Consulting What does the future of Cell & Gene Therapy look like? Sponsored by: Clinical Ink For faster deployment, improved patient engagement, and better-quality data — go where your patients are. GO BYOD with Lunexis™ from Clinical Ink. Sponsored by: BBK Worldwide Create a more diverse and inclusive clinical trial enrollment and engagement environment by learning the barriers to participation and the strategies to overcome them. Sponsored by: Thermo Fisher Scientific Autologous cell and gene therapy workflows involve isolating cells from an individual, engineering the cells, expanding and concentrating them, and infusing them back into the patient. Optimized automation of certain steps of the workflow may decrease hands-on time and the cost of the cell manufacturing process. Sponsored By: Veeva Learn how to develop a standards program that has your full team’s buy-in and improves the efficiency and quality of your clinical trials. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored By: August Bioservices How has COVID-19 impacted CRO/CDMO customer (dis)satisfaction and outsourcing decisions for pharma and biotech companies in 2021 and beyond? Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. | 
